Piramal Enterprises has received an approval for the issuance of Secured, Rated, Listed, Redeemable, Principal Protected, Market Linked Non-Convertible Debentures (NCDs) up to Rs 50 crore along with an option to retain oversubscription of up to Rs 650 crore aggregating up to Rs 700 crore on private placement basis. The said debentures are proposed to be listed on Debt Segment and Capital Market Segment of National Stock Exchange (NSE) and BSE. The Meeting of Administrative Committee (‘Committee’) of the Board of Directors held on May 4, 2022, has approved the same.
Piramal Enterprises is one of India’s large diversified companies, with a presence in Pharmaceuticals, Healthcare Information Management and Financial Services.
